Thrivent Financial for Lutherans Has $124.87 Million Stake in Cigna Group $CI

Thrivent Financial for Lutherans lifted its position in Cigna Group (NYSE:CI) by 55.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 453,677 shares of the health services provider’s stock after purchasing an additional 162,023 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Cigna Group were worth $124,866,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of CI. Beacon Financial Strategies CORP acquired a new position in shares of Cigna Group in the fourth quarter valued at $28,000. Lodestone Wealth Management LLC acquired a new position in shares of Cigna Group in the fourth quarter valued at $32,000. Collier Financial acquired a new position in shares of Cigna Group in the third quarter valued at $34,000. Activest Wealth Management raised its stake in shares of Cigna Group by 1,050.0% in the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 126 shares in the last quarter. Finally, True Wealth Design LLC raised its stake in shares of Cigna Group by 116.4% in the fourth quarter. True Wealth Design LLC now owns 158 shares of the health services provider’s stock valued at $43,000 after purchasing an additional 85 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Stock Performance

Shares of NYSE:CI opened at $294.39 on Friday. The business’s fifty day moving average price is $274.94 and its two-hundred day moving average price is $275.90. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $338.89. The stock has a market capitalization of $77.87 billion, a price-to-earnings ratio of 12.48, a price-to-earnings-growth ratio of 1.05 and a beta of 0.30. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, analysts predict that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio is presently 26.45%.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Jefferies Financial Group lowered their price target on Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research report on Monday, April 20th. Cantor Fitzgerald upped their price target on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. Deutsche Bank Aktiengesellschaft upped their price target on Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a research report on Tuesday, February 10th. Finally, Piper Sandler lowered their price target on Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $338.35.

Insider Transactions at Cigna Group

In other news, insider Everett Neville sold 1,719 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider owned 32,647 shares in the company, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 205,904 shares of company stock worth $60,277,068. Insiders own 0.60% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.